HomeKRBP • OTCMKTS
add
Kiromic Biopharma Inc
Previous close
$0.93
Year range
$0.75 - $3.78
Market cap
1.43M USD
Avg Volume
1.12K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.60M | 18.93% |
Net income | -7.44M | -77.28% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -6.05M | -21.24% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.92M | -33.23% |
Total assets | 10.24M | -28.02% |
Total liabilities | 19.53M | 4.34% |
Total equity | -9.29M | — |
Shares outstanding | 1.55M | — |
Price to book | -0.15 | — |
Return on assets | -145.38% | — |
Return on capital | -242.31% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -7.44M | -77.28% |
Cash from operations | -1.93M | 63.06% |
Cash from investing | -219.00K | -123.47% |
Cash from financing | 1.03M | -85.33% |
Net change in cash | -1.12M | -167.00% |
Free cash flow | -2.91M | 49.09% |
About
Founded
2006
Headquarters
Website
Employees
35
